TY - JOUR
T1 - Demographics, comorbidities and outcomes in hospitalized Covid-19 patients in rural southwest Georgia
AU - Shah, Priyank
AU - Owens, Jack
AU - Franklin, James
AU - Mehta, Akshat
AU - Heymann, William
AU - Sewell, William
AU - Hill, Jennifer
AU - Barfield, Krista
AU - Doshi, Rajkumar
N1 - Publisher Copyright:
© 2020, © 2020 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2020
Y1 - 2020
N2 - Background: There is limited data on outcomes in patients with coronavirus disease 2019 (Covid-19) in rural United States (US). This study aimed to describe the demographics, and outcomes of hospitalized Covid-19 patients in rural Southwest Georgia. Methods: Using electronic medical records, we analyzed data from all hospitalized Covid-19 patients who either died or survived to discharge between 2 March 2020 and 6 May 2020. Results: Of the 522 patients, 92 died in hospital (17.6%). Median age was 63 years, 58% were females, and 87% African-Americans. Hypertension (79.7%), obesity (66.5%) and diabetes mellitus (42.3%) were the most common comorbidities. Males had higher overall mortality compared to females (23 v 13.8%). Immunosuppression [odds ratio (OR) 3.6; (confidence interval (CI): 1.52–8.47, p=.003)], hypertension (OR 3.36; CI:1.3–8.6, p=.01), age ≥65 years (OR 3.1; CI:1.7–5.6, p<.001) and morbid obesity (OR 2.29; CI:1.11–4.69, p=.02), were independent predictors of in-hospital mortality. Female gender was an independent predictor of decreased in-hospital mortality. Mortality in intubated patients was 67%. Mortality was 8.9% in <50 years, compared to 20% in ≥50 years. Conclusions: Immunosuppression, hypertension, age ≥ 65 years and morbid obesity were independent predictors of mortality, whereas female gender was protective for mortality in hospitalized Covid-19 patients in rural Southwest Georgia.KEY MESSAGES Patients hospitalized with Covid-19 in rural US have higher comorbidity burden. Immunosuppression, hypertension, age ≥ 65 years and morbid obesity are independent predictors of increased mortality. Female gender is an independent predictor of reduced mortality.
AB - Background: There is limited data on outcomes in patients with coronavirus disease 2019 (Covid-19) in rural United States (US). This study aimed to describe the demographics, and outcomes of hospitalized Covid-19 patients in rural Southwest Georgia. Methods: Using electronic medical records, we analyzed data from all hospitalized Covid-19 patients who either died or survived to discharge between 2 March 2020 and 6 May 2020. Results: Of the 522 patients, 92 died in hospital (17.6%). Median age was 63 years, 58% were females, and 87% African-Americans. Hypertension (79.7%), obesity (66.5%) and diabetes mellitus (42.3%) were the most common comorbidities. Males had higher overall mortality compared to females (23 v 13.8%). Immunosuppression [odds ratio (OR) 3.6; (confidence interval (CI): 1.52–8.47, p=.003)], hypertension (OR 3.36; CI:1.3–8.6, p=.01), age ≥65 years (OR 3.1; CI:1.7–5.6, p<.001) and morbid obesity (OR 2.29; CI:1.11–4.69, p=.02), were independent predictors of in-hospital mortality. Female gender was an independent predictor of decreased in-hospital mortality. Mortality in intubated patients was 67%. Mortality was 8.9% in <50 years, compared to 20% in ≥50 years. Conclusions: Immunosuppression, hypertension, age ≥ 65 years and morbid obesity were independent predictors of mortality, whereas female gender was protective for mortality in hospitalized Covid-19 patients in rural Southwest Georgia.KEY MESSAGES Patients hospitalized with Covid-19 in rural US have higher comorbidity burden. Immunosuppression, hypertension, age ≥ 65 years and morbid obesity are independent predictors of increased mortality. Female gender is an independent predictor of reduced mortality.
KW - Covid-19
KW - baseline characteristics
KW - demographics
KW - outcomes
KW - rural US
UR - http://www.scopus.com/inward/record.url?scp=85087919908&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087919908&partnerID=8YFLogxK
U2 - 10.1080/07853890.2020.1791356
DO - 10.1080/07853890.2020.1791356
M3 - Article
C2 - 32620056
AN - SCOPUS:85087919908
SN - 0785-3890
SP - 354
EP - 360
JO - Medical Biology
JF - Medical Biology
ER -